Drug Profile
Pibaxizine
Alternative Names: J 028; UCB 20028; UCB J 028Latest Information Update: 05 Aug 2002
Price :
$50
*
At a glance
- Originator UCB
- Class Piperazines; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Chronic obstructive pulmonary disease
Most Recent Events
- 31 Dec 1997 Discontinued - Phase-II for Chronic obstructive pulmonary disease in Belgium (unspecified route)
- 03 Apr 1997 Phase-II clinical trials for Chronic obstructive pulmonary disease in Belgium (Unknown route)
- 20 Aug 1996 J 028 is now called pibaxizine